ML-SYS / 2026.07NON-CLINICAL RESEARCH MATERIALSORIGIN DECLARED BY LOT

← Compound index

RM-TRS / Tissue, repair and matrix signalling

Vialox

Also known as: Pentapeptide-3 · Pentapeptide-3V · GPRPA-NH2

Related-compound evidence onlyEvidence grade D: Related-compound evidence only

Grade describes the published research on the molecule. It is not a quality score, a safety score, or a release state.

What this is

Vialox is the amidated GPRPA pentapeptide. It should not be collapsed into SYN-AKE, which has a different beta-amino-acid and benzylamide structure.

Evidence position

The exact identity is documented, but direct independent human evidence is insufficient. The entry remains Grade D.

What the record does not establish

Mechanistic analogy and supplier summaries do not establish clinical performance, finished-formulation equivalence or lot identity.

Sources

  • 01
    Pentapeptide-3 compound recordPubChem
    Shows
    Registry identity, GPRPA-amide sequence, formula and Vialox synonyms
    Does not show
    Chemical identity does not establish topical efficacy or lot quality
  • 02
    Topical Peptide Treatments with Effective Anti-Aging ResultsCosmetics
    Shows
    Peer-reviewed review that identifies Pentapeptide-3/Vialox, its GPRPA sequence and the available formulation-level results
    Does not show
    Review-level discussion; the cited performance data are not an independent trial of an authenticated raw-material lot
  • 03
    Vialox market listingCore Peptides
    Shows
    Current research-market use of the Vialox and Pentapeptide-3 names
    Does not show
    Supplier copy is not independent evidence or lot verification

External database index

LIVE DATABASE INDEX / SEPARATE FROM CURATED EVIDENCE

Records below come directly from public scientific databases. They help find relevant material, but do not affect the evidence grade until they are matched to the molecule and added to the curated source list.

Related compounds